Literature DB >> 15106849

Gamma/beta oscillation and sensory gating deficit in schizophrenia.

L Elliot Hong1, Ann Summerfelt, Robert P McMahon, Gunvant K Thaker, Robert W Buchanan.   

Abstract

Sensory gating can be measured by the suppression of auditory evoked potentials in a paired-click paradigm. The normal gating of the P50 response to the second stimulus (S2) is impaired in many schizophrenic patients. Various in vitro and in vivo evoked potential paradigms have shown that a stimulus evokes early gamma frequency oscillation, which is followed by beta frequency oscillation. The gamma-to-beta shift in response to the first stimulus (SI) in the paired-click paradigm may contain critical electrophysiological signals that modulate the S2 suppression. The results of the present study showed that post-SI beta frequency response was inversely correlated to the S2 P50 response in patients with schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15106849     DOI: 10.1097/00001756-200401190-00030

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  30 in total

1.  Event-related potentials and changes of brain rhythm oscillations during working memory activation in patients with first-episode psychosis.

Authors:  Pascal Missonnier; François R Herrmann; Adriano Zanello; Maryse Badan Bâ; Logos Curtis; Diana Canovas; Fabrice Chantraine; Jonas Richiardi; Panteleimon Giannakopoulos; Marco C G Merlo
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

2.  Short-term habituation of auditory evoked potential and neuromagnetic field components in dependence of the interstimulus interval.

Authors:  Timm Rosburg; Karen Zimmerer; Ralph Huonker
Journal:  Exp Brain Res       Date:  2010-08-14       Impact factor: 1.972

3.  Gamma and beta neural activity evoked during a sensory gating paradigm: effects of auditory, somatosensory and cross-modal stimulation.

Authors:  Michael A Kisley; Zoe M Cornwell
Journal:  Clin Neurophysiol       Date:  2006-09-27       Impact factor: 3.708

4.  Sensory gating event-related potentials and oscillations in schizophrenia patients and their unaffected relatives.

Authors:  Mei-Hua Hall; Grantley Taylor; Dean F Salisbury; Deborah L Levy
Journal:  Schizophr Bull       Date:  2010-04-02       Impact factor: 9.306

5.  Early auditory gamma-band responses in patients at clinical high risk for schizophrenia.

Authors:  Veronica B Perez; Brian J Roach; Scott W Woods; Vinod H Srihari; Thomas H McGlashan; Judith M Ford; Daniel H Mathalon
Journal:  Suppl Clin Neurophysiol       Date:  2013

6.  Dopaminergic contributions to hippocampal pathophysiology in schizophrenia: a computational study.

Authors:  Peter J Siekmeier; David P vanMaanen
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

7.  Event-related potential abnormalities in schizophrenia: a failure to "gate in" salient information?

Authors:  Colleen A Brenner; Paul D Kieffaber; Brett A Clementz; Jason K Johannesen; Anantha Shekhar; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Res       Date:  2009-07-23       Impact factor: 4.939

8.  Sustained Modafinil Treatment Effects on Control-Related Gamma Oscillatory Power in Schizophrenia.

Authors:  Michael J Minzenberg; Jong H Yoon; Yaoan Cheng; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2015-09-02       Impact factor: 7.853

9.  Smooth pursuit eye movement, prepulse inhibition, and auditory paired stimuli processing endophenotypes across the schizophrenia-bipolar disorder psychosis dimension.

Authors:  Elena I Ivleva; Amanda F Moates; Jordan P Hamm; Ira H Bernstein; Hugh B O'Neill; Darwynn Cole; Brett A Clementz; Gunvant K Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2013-04-18       Impact factor: 9.306

10.  Nonlinear analysis of electroencephalogram in schizophrenia patients with persistent auditory hallucination.

Authors:  Seung-Hwan Lee; Jung-Suk Choo; Wu-Young Im; Jeong-Ho Chae
Journal:  Psychiatry Investig       Date:  2008-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.